Nice | Omalizumab for chronic urticaria

20th July 2015 by Louise Hudman

Nice | Omalizumab for chronic urticaria

This is a new guideline from Nice recommending that omalizumab can be considered in chronic urticaria.

Apparently it is already being used on occasion, though due to cost, it is more common for immunosuppressants like ciclosporin to be used. Omalizumab is preferred because of less need for monitoring.

It is not disease modifying and repeat courses are likely to be required.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"The quality and contents of the magazine are superb. It's wonderful that GP locums now have a voice and are seen as a vital part of the medical workforce."

Dr Irene Bainbridge

See the full list of features within our NASGP membership plans

Membership